Pharmaceuticals, Biotechnology and Life Sciences
ENHERTU is the second innovative oncology medicine to be launched in Japan from the oncology pipeline of Daiichi Sankyo in…
ENHERTU is the second innovative oncology medicine to be launched in Japan from the oncology pipeline of Daiichi Sankyo in…
ENHERTU is the second innovative oncology medicine to be launched in Japan from the oncology pipeline of Daiichi Sankyo in…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#celltherapy–Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has completed the construction…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#celltherapy–Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has completed the construction…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#celltherapy–Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has completed the construction…
Phase 1 clinical study in patients with advanced solid tumor expected to start in 3Q2020 SEONGNAM-SI, Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd.…
Phase 1 clinical study in patients with advanced solid tumor expected to start in 3Q2020 SEONGNAM-SI, Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd.…
Phase 1 clinical study in patients with advanced solid tumor expected to start in 3Q2020 SEONGNAM-SI, Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd.…
Launched from Versant’s Ridgeline Discovery Engine Based on work from Rajesh Chopra, Ian Collins and Nicolas Thomä, leaders in ubiquitin…